Merck & Co. - Opthamology Business' Unit Acquisition

Merck & Co. - Opthamology Business raised a round of funding on December 03, 2015. Investors include Mundipharma International.

Merck & Co. (NYSE: MRK) is a global healthcare company. Through its prescription medicines, vaccines, biologic therapies, and animal health products, the company works with customers and operates in m…

Articles about Merck & Co. - Opthamology Business' Unit Acquisition: